USA - Eli Lilly's experimental drug Donanemab slowed the progression of Alzheimer's by 60% for patients in the earliest stages of the brain-wasting disease.
UNITED STATES - Experts say we could be entering the era of Alzheimer's treatments, after the second drug in under a year has been shown to...
